Stephan U. Gerlach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Stephan U. Gerlach has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Héctor Herranz
Affiliation Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark
3 shared publications - David Bilder
Department of Molecular and Cell Biology, University of California-Berkeley, Berkeley, CA 94720, USA
2 shared publications - Geert de Vreede
University of California-Berkeley Department of Molecular and Cell Biology Berkeley, CA 94720 , USA
2 shared publications - Erik Michael Danielsen
Department of Cellular and Molecular Medicine, the Panum Institute, Faculty of Health Sciences, University of Copenhagen, Denmark
1 shared publication Karen C. Soegaard
Department of Biology, University of Copenhagen, Universitetsparken 15, 2100 Copenhagen, Denmark
1 shared publication- Kim Rewitz
Department of Biology, University of Copenhagen, Copenhagen, Denmark
1 shared publication
Latest Publications
- Open Access
- 10 November 2022
- Published by The Company of Biologists in Biology Open
- Vol. 11 (11)
PTP10D-mediated cell competition is not obligately required for elimination of polarity-deficient clones
Animal organs maintain tissue integrity and ensure removal of aberrant cells through several types of surveillance mechanisms. One prominent example is the elimination of polarity-deficient mutant cells within developing Drosophila imaginal discs. This has been proposed to require heterotypic cell competition dependent on the receptor tyrosine phosphatase PTP10D within the mutant cells. We report here experiments to test this requirement in various contexts and find that PTP10D is not obligately required for the removal of scribble (scrib) mutant and similar polarity-deficient cells. Our experiments used identical stocks with which another group can detect the PTP10D requirement, and our results do not vary under several husbandry conditions including high and low protein food diets. Although we are unable to identify the source of the discrepant results, we suggest that the role of PTP10D in polarity-deficient cell elimination may not be absolute.
- 10 November 2022
- Published by The Company of Biologists in Biology Open
- Vol. 11 (11)
Open AccessPTP10D-mediated cell competition is not obligately required for elimination of polarity-deficient clones
Animal organs maintain tissue integrity and ensure removal of aberrant cells through several types of surveillance mechanisms. One prominent example is the elimination of polarity-deficient mutant cells within developing Drosophila imaginal discs. This has been proposed to require heterotypic cell competition dependent on the receptor tyrosine phosphatase PTP10D within the mutant cells. We report here experiments to test this requirement in various contexts and find that PTP10D is not obligately required for the removal of scribble (scrib) mutant and similar polarity-deficient cells. Our experiments used identical stocks with which another group can detect the PTP10D requirement, and our results do not vary under several husbandry conditions including high and low protein food diets. Although we are unable to identify the source of the discrepant results, we suggest that the role of PTP10D in polarity-deficient cell elimination may not be absolute.
- 14 April 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 376 (6590) , 297-301
Epithelial monitoring through ligand-receptor segregation ensures malignant cell elimination
Animals have evolved mechanisms, such as cell competition, to remove dangerous or nonfunctional cells from a tissue. Tumor necrosis factor signaling can eliminate clonal malignancies from Drosophila imaginal epithelia, but why this pathway is activated in tumor cells but not normal tissue is unknown. We show that the ligand that drives elimination is present in basolateral circulation but remains latent because it is spatially segregated from its apically localized receptor. Polarity defects associated with malignant transformation cause receptor mislocalization, allowing ligand binding and subsequent apoptotic signaling. This process occurs irrespective of the neighboring cells’ genotype and is thus distinct from cell competition. Related phenomena at epithelial wound sites are required for efficient repair. This mechanism of polarized compartmentalization of ligand and receptor can generally monitor epithelial integrity to promote tissue homeostasis.
- 14 April 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 376 (6590) , 297-301
Epithelial monitoring through ligand-receptor segregation ensures malignant cell elimination
Animals have evolved mechanisms, such as cell competition, to remove dangerous or nonfunctional cells from a tissue. Tumor necrosis factor signaling can eliminate clonal malignancies from Drosophila imaginal epithelia, but why this pathway is activated in tumor cells but not normal tissue is unknown. We show that the ligand that drives elimination is present in basolateral circulation but remains latent because it is spatially segregated from its apically localized receptor. Polarity defects associated with malignant transformation cause receptor mislocalization, allowing ligand binding and subsequent apoptotic signaling. This process occurs irrespective of the neighboring cells’ genotype and is thus distinct from cell competition. Related phenomena at epithelial wound sites are required for efficient repair. This mechanism of polarized compartmentalization of ligand and receptor can generally monitor epithelial integrity to promote tissue homeostasis.
- Open Access
- 3 June 2020
- Published by The Royal Society in Open Biology
- Vol. 10 (6) , 200060
Genomic instability and cancer: lessons from Drosophila
Cancer is a genetic disease that involves the gradual accumulation of mutations. Human tumours are genetically unstable. However, the current knowledge about the origins and implications of genomic instability in this disease is limited. Understanding the biology of cancer requires the use of animal models. Here, we review relevant studies addressing the implications of genomic instability in cancer by using the fruit fly, Drosophila melanogaster , as a model system. We discuss how this invertebrate has helped us to expand the current knowledge about the mechanisms involved in genomic instability and how this hallmark of cancer influences disease progression.
- 3 June 2020
- Published by The Royal Society in Open Biology
- Vol. 10 (6) , 200060
Open AccessGenomic instability and cancer: lessons from Drosophila
Cancer is a genetic disease that involves the gradual accumulation of mutations. Human tumours are genetically unstable. However, the current knowledge about the origins and implications of genomic instability in this disease is limited. Understanding the biology of cancer requires the use of animal models. Here, we review relevant studies addressing the implications of genomic instability in cancer by using the fruit fly, Drosophila melanogaster , as a model system. We discuss how this invertebrate has helped us to expand the current knowledge about the mechanisms involved in genomic instability and how this hallmark of cancer influences disease progression.
- Open Access
- 22 July 2019
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 2 (4) , e201900381
The miRNAbantamregulates growth and tumorigenesis by repressing the cell cycle regulatortribbles
One of the fundamental issues in biology is understanding how organ size is controlled. Tissue growth has to be carefully regulated to generate well-functioning organs, and defects in growth control can result in tumor formation. The Hippo signaling pathway is a universal growth regulator and has been implicated in cancer. InDrosophila, the Hippo pathway acts through the miRNAbantamto regulate cell proliferation and apoptosis. Even though thebantamtargets regulating apoptosis have been determined, the target genes controlling proliferation have not been identified thus far. In this study, we identify the genetribblesas a directbantamtarget gene. Tribbles limits cell proliferation by suppressing G2/M transition. We show thattribblesregulation bybantamis central in controlling tissue growth and tumorigenesis. We expand our study to other cell cycle regulators and show that deregulated G2/M transition can collaborate with oncogene activation driving tumor formation.
- 22 July 2019
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 2 (4) , e201900381
Open AccessThe miRNAbantamregulates growth and tumorigenesis by repressing the cell cycle regulatortribbles
One of the fundamental issues in biology is understanding how organ size is controlled. Tissue growth has to be carefully regulated to generate well-functioning organs, and defects in growth control can result in tumor formation. The Hippo signaling pathway is a universal growth regulator and has been implicated in cancer. InDrosophila, the Hippo pathway acts through the miRNAbantamto regulate cell proliferation and apoptosis. Even though thebantamtargets regulating apoptosis have been determined, the target genes controlling proliferation have not been identified thus far. In this study, we identify the genetribblesas a directbantamtarget gene. Tribbles limits cell proliferation by suppressing G2/M transition. We show thattribblesregulation bybantamis central in controlling tissue growth and tumorigenesis. We expand our study to other cell cycle regulators and show that deregulated G2/M transition can collaborate with oncogene activation driving tumor formation.
- Open Access
- 1 May 2018
- Published by Elsevier in Cell Reports
- Vol. 23 (5) , 1491-1503
Yorkie and JNK Control Tumorigenesis in Drosophila Cells with Cytokinesis Failure
- 1 May 2018
- Published by Elsevier in Cell Reports
- Vol. 23 (5) , 1491-1503
Open AccessYorkie and JNK Control Tumorigenesis in Drosophila Cells with Cytokinesis Failure
- 1 June 2017
- Published by Elsevier in Current Biology
- Vol. 27 (11) , 1652-1659.e4
Warts Signaling Controls Organ and Body Growth through Regulation of Ecdysone
- 1 June 2017
- Published by Elsevier in Current Biology
- Vol. 27 (11) , 1652-1659.e4
Warts Signaling Controls Organ and Body Growth through Regulation of Ecdysone